Changes in circulating levels of BAFF, which are genetically regulated and lead to its increase, seem to be strongly correlated with the risk of autoimmunity, as Genome-wide genetic association (GWAS) studies on MS and SLE patients reveal 20. This evidence concerns the gene TNFSF13B and myeloid sarcoma.